These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8179352)
21. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Budzyńska A; Marek T; Nowak A; Kaczor R; Nowakowska-Dulawa E Endoscopy; 2001 Sep; 33(9):766-72. PubMed ID: 11558030 [TBL] [Abstract][Full Text] [Related]
22. Topical calcipotriol ointment in the treatment of morphea. Tay YK J Dermatolog Treat; 2003 Dec; 14(4):219-21. PubMed ID: 14660267 [TBL] [Abstract][Full Text] [Related]
23. [Therapeutic effectiveness of treatment of patients with scleroderma at the Pyatigorsk Spa]. Braĭtsev AV; Kessel' VP; Marzeeva GI; Shliapak EA; Angelova VS Vestn Dermatol Venerol; 1971 Oct; 45(10):35-9. PubMed ID: 5134075 [No Abstract] [Full Text] [Related]
24. Oral steroids in initial treatment of acute sciatica. Holve RL; Barkan H J Am Board Fam Med; 2008; 21(5):469-74. PubMed ID: 18772303 [TBL] [Abstract][Full Text] [Related]
25. [Piascledine in the treatment of scleroderma]. Szczepański A; Dabrowska H; Moskalewska K Przegl Dermatol; 1974; 61(4):525-7. PubMed ID: 4849404 [No Abstract] [Full Text] [Related]
26. Topical tacrolimus in the treatment of localized scleroderma. Mancuso G; Berdondini RM Eur J Dermatol; 2003; 13(6):590-2. PubMed ID: 14721783 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of localized scleroderma with systemic administration of a corticosteroid hormone]. Yanase S; Yamazaki S; Furuya T Nihon Hifuka Gakkai Zasshi; 1987 Apr; 97(5):581-5. PubMed ID: 3613220 [No Abstract] [Full Text] [Related]
34. PUVA treatment in sclerodermatoid spectrum of dermatologic diseases: our initial experience. Baum S; Pavlotsky F; Shpiro D; Trau H Isr Med Assoc J; 2004 Sep; 6(9):563-4. PubMed ID: 15373320 [No Abstract] [Full Text] [Related]
35. The in vitro and in vivo effect of corticosteroids on basophil releasability in patients with mild and severe bronchial asthma. Kivity S; Onn A; Agami O; Fireman E Clin Exp Allergy; 1997 Aug; 27(8):909-14. PubMed ID: 9291288 [TBL] [Abstract][Full Text] [Related]
36. Case 2: presentation. Poor response to asthma treatment. Payne DN; Adcocz JM Paediatr Respir Rev; 2001 Jun; 2(2):196, 197-8. PubMed ID: 12531071 [No Abstract] [Full Text] [Related]
38. Rheumatoid factor isotypes in localized scleroderma. Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K Clin Exp Dermatol; 2005 Jul; 30(4):405-8. PubMed ID: 15953082 [TBL] [Abstract][Full Text] [Related]
39. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma]. Sych LI; Trofimova LIa Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538 [No Abstract] [Full Text] [Related]
40. [Corticosteroids in the treatment of severe icteric hepatitis. Clincal analysis of 23 cases]. Zhonghua Yi Xue Za Zhi; 1974; (12):771-4, 215-6. PubMed ID: 4217260 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]